MannKind | L'Utile Operativo



Operating Profit Cambiamento Data
Adma Biologics USD 37.08M 2.56M 2024-12
Dynavax Technologies USD 10.86M 34.49M 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Halozyme Therapeutics USD 202.44M 60.91M 2025-06
Insmed USD -253876000 5.74M 2025-06
MacroGenics USD -16587000 70.78M 2024-12
MannKind USD -43411000 65.7M 2025-06
Merck USD 6.36B 494M 2025-06
Novo Nordisk DKK 38.79B 4.97B 2025-03
Pfizer USD 2.6B 1.06B 2025-06
Sanofi EUR 1.71B 573M 2025-06
Xencor USD -33172000 10.01M 2025-06


MannKind L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.